Penetrating keratoplasty for silicone oil keratopathy

Clin Exp Ophthalmol. 2001 Oct;29(5):303-6. doi: 10.1046/j.1442-9071.2001.00438.x.

Abstract

Purpose: Penetrating keratoplasty for silicone oil keratopathy is associated with high risks and limited visual prognosis. This study examined the outcomes and factors influencing graft failure.

Methods: A retrospective, non-comparative, interventional case series of patients attending Moorfields Eye Hospital, London.

Results: A total of 24 penetrating keratoplasties were performed in 17 patients (13 men and four women) from 1991 to 2000. The mean age of patients undergoing surgery was 43.6 years (range 17-84 years, SD +/- 21.0). Silicone oil was removed before or during the time of initial penetrating keratoplasty in nine patients (52.9%) and left in situ in eight patients (47.1%). Ten out of 24 grafts survived (41.7%). The median duration of graft survival was 21 months (range 2 weeks-98 months) with median duration of follow up 33 months (range 2-100 months). At final follow up, the number of patients with a clear graft who had oil removed before or during the time of penetrating keratoplasty was seven out of 10 (70.0%). Risk factors for graft failure included hypotony, multiple keratoplasty, corneal neovascularization, rejection episode, silicone oil left in situ and postoperative glaucoma.

Conclusions: Management of these complex patients requires a combined approach from anterior segment and vitreoretinal subspecialties. The long-term success of the graft can be improved if silicone oil is removed prior or during the time of penetrating keratoplasty.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Corneal Diseases / chemically induced
  • Corneal Diseases / surgery*
  • Female
  • Graft Rejection / etiology
  • Humans
  • Keratoplasty, Penetrating*
  • Male
  • Middle Aged
  • Retinal Detachment / surgery
  • Retrospective Studies
  • Risk Factors
  • Silicone Oils / adverse effects*
  • Treatment Outcome
  • Visual Acuity

Substances

  • Silicone Oils